samsung biologics
Samsung BioLogics to Construct World’s Largest Biopharmaceutical Manufacturing Plant
Samsung BioLogics’ US$724 million plant is set to begin operations in the fourth quarter of 2018.
Samsung BioLogics To Manufacture Antibody Drug For Bristol-Myers Squibb
Samsung BioLogics will manufacture a commercial antibody cancer drug for Bristol-Myers Squibb at its Songdo Incheon plant in South Korea.